324483 Sigma-AldrichEbselen - CAS 60940-34-3 - Calbiochem
A cell-permeable, non-selective inhibitor of COX-1 and COX-2.
More>> A cell-permeable, non-selective inhibitor of COX-1 and COX-2. Less<<Ebselen - CAS 60940-34-3 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: 2-Phenyl-1,2-benzisoselenazol-3(2H)-one, PZ51
Recommended Products
概述
Replacement Information |
---|
重要规格表
CAS # | Empirical Formula |
---|---|
60940-34-3 | C₁₃H₉NOSe |
Products
产品目录编号 | 包装 | 数量 / 包装 | |
---|---|---|---|
324483-5MGCN | 玻璃瓶 | 5 mg |
Product Information | |
---|---|
CAS number | 60940-34-3 |
ATP Competitive | N |
Form | Lyophilized solid |
Hill Formula | C₁₃H₉NOSe |
Chemical formula | C₁₃H₉NOSe |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | COX-1, COX-2 |
Purity | ≥98% by TLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
产品目录编号 | GTIN |
324483-5MGCN | 04055977197242 |
Documentation
Ebselen - CAS 60940-34-3 - Calbiochem MSDS
职位 |
---|
Ebselen - CAS 60940-34-3 - Calbiochem 分析证书
标题 | 批号 |
---|---|
324483 |
参考
参考信息概述 |
---|
Shimohashi, N., et al. 2000. J. Cell Biochem. 78, 595. Ramakrishnan, N., et al. 1996. Biochem. Pharmacol. 51, 1443. Ullrich, V., et al. 1996. Biochem. Pharmacol. 52, 15. Dawson, D.A., et al. 1995. Neurosci. Lett. 185, 65. Wang, J.F., et al. 1992. Hepatology 5, 112. Maiorino, M., et al. 1988. Biochem. Pharmacol. 37, 2267. Parnham, M.J., and Graf, E. 1987. Biochem. Pharmacol. 36, 3095. Parnham, M.J., and Kindt, S. 1984. Biochem. Pharmacol. 33, 3247. |
小册子
标题 |
---|
Alzheimer's Disease Brochure & Technical Guide |